Alzheimer's disease (AD) is pathologically defined by the presence of fibrillar amyloid β (Aβ)
peptide in extracellular senile plaques and tau filaments in intracellular neurofibrillary …

Similar to dementia, the risk for develo** type 2 diabetes mellitus (T2DM) increases with
age, and T2DM also increases the risk for dementia, particularly Alzheimer's disease (AD) …

The COVID-19 pandemic is an unprecedented global challenge, and point-of-care
diagnostic classifiers are urgently required. Here, we present a platform for ultra-high …

With Alzheimer's disease (AD) exhibiting reduced ability of neural stem cell renewal, we
hypothesized that de novo mutations controlling embryonic development, in the form of brain …

Studies suggest that dysfunction of brain-derived neurotrophic factor (BDNF) is a possible
contributor to the pathology and symptoms of Alzheimer's disease (AD). Several studies …

Background Individuals affected with autism often suffer additional co-morbidities such as
intellectual disability. The genes contributing to autism cluster on a relatively limited number …

The complexity of Alzheimer's disease (AD) and its long prodromal phase poses challenges
for early diagnosis and yet allows for the possibility of the development of disease modifying …

Autism spectrum disorder (ASD) and Alzheimer's disease (AD) are two different neurological
disorders that share common clinical features, such as language impairment, executive …

The NAP motif of activity-dependent neuroprotective protein (ADNP) enhanced memory
scores in patients suffering from mild cognitive impairment and protected activities of daily …

Autism spectrum disorder (ASD) comprises a range of neurological conditions that affect
individuals' ability to communicate and interact with others. People with ASD often exhibit …